CLINICAL TRIAL UPDATE: Application of XV Technology to lung transplant added to clinical trials program

CLINICAL TRIAL UPDATE: Application of XV Technology to lung transplant added to clinical trials program

Lung transplants offer people afflicted with incurable respiratory disease the prospect of a better quality of life – XV Technology optimises success of expensive, resource-intensive procedures.

Alfred Health-based ‘FIT’ Study announced today involves 40 patients affected by conditions including interstitial lung disease, severe COPD, pulmonary hypertension and cystic fibrosis.

Learn more about our clinical trials program here: https://4dmedical.com/clinical-trials/